Syndromes such as Li-Fraumeni (TP53 mutations), Cowden syndrome (PTEN mutations), and hereditary breast and ovarian cancer syndrome (BRCA1/2 mutations) have all been implicated in predisposition to multiple tumors [14,15]. This evidence concerns the gene TP53 and hereditary breast ovarian cancer syndrome.